Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- CheckyesterdayChange DetectedThe page now renders a 403 Forbidden error page instead of the study content, replacing the study details with a generic error screen. This blocks access to the trial information and navigation, effectively making the page unusable for viewing the study record.SummaryDifference21%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA US NIH grant/contract funding line was added to the study's identifiers. The page revision was updated to v3.6.6, replacing v3.6.5, indicating an updated study record.SummaryDifference0.1%

- Check43 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5. This reflects a minor update to the page's template or documentation without altering the displayed study details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a software/content update to the page release.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page revision tag was updated to v3.6.3, representing a metadata/version update. No substantive study information or functionality appears to be altered.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now shows an updated site revision label (Revision: v3.6.2), replacing the previous Revision: v3.6.0, indicating a small backend/content management update to the page.SummaryDifference0.0%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.